Project
CCX_Chemocentryx CL010 CCX168 (Avacopan)
Completed ยท 2017 until 2021
Forrer Silvia, Hutz Carina Liane, Bartz-Batliner Mira, Rubbert-Roth Andrea, Neumann Thomas
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2017
End Date
2021
Financing
Industry
Keywords
ANCA-Associated Vasculitis treated concomitantly with rituximab or cyclophosphamid/azathioprine, Avacopan
Brief description/objective
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in
Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-
Associated Vasculitis Treated Concomitantly with Rituximab or
Cyclophosphamide/Azathioprine